← Back to Clinical Trials
Recruiting NCT07356999

NCT07356999 Characterization of Visual Perception Impairments in Patients With Idiopathic Scoliosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07356999
Status Recruiting
Phase
Sponsor Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Condition Idiopathic Scoliosis
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2026-04-21
Primary Completion 2027-09-01

Eligibility & Interventions

Sex All sexes
Min Age 11 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Motion Analysis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2026-04-21 with a primary completion date of 2027-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Scoliosis is more than just a curve in the spine; it is a complex, 3D twisting of the backbone. While it can be caused by birth defects or tumors, the most common type-idiopathic scoliosis-appears in healthy teenagers for no clearly known reason. The Theory of Balance Researchers believe that scoliosis might actually be caused by a "glitch" in how the body stays upright. Instead of the spine curving on its own, the curve might be the body's way of compensating for a poor sense of balance. To stay balanced, the human brain relies on three main "inputs": 1. The Vestibular System: Located in the inner ear (detects movement). 2. Proprioception: The body's "inner map" (sensing where your limbs are). 3. Vision: Seeing the world around you to stay oriented. The Goal of the Study Even though humans rely heavily on their eyes to stay balanced, the role of vision in scoliosis has not been studied very much. This experiment aims to test the hypothesis that teenagers with scoliosis have trouble processing visual information to maintain their posture. By using advanced motion analysis, researchers want to see if a "misunderstanding" of visual cues is contributing to the spinal deformity.

Eligibility Criteria

Inclusion Criteria: Group Scoliosis: * Girls or boys aged 11 to 18 inclusive. * Patients with progressive idiopathic scoliosis * Candidates for either orthopedic (brace) or surgical (arthrodesis correction) treatment for which a pre-therapeutic multimodal assessment is planned. Control group: \- Girls or boys aged 11 to 18 inclusive. Exclusion Criteria: The following individuals will not be included: * Individuals with another musculoskeletal disorder. * Individuals with a neurosensory disorder that may affect the balance of the trunk or lower limbs. * Individuals with uncorrected visual perception disorders (visual check within 12 months prior to the examination). * Lack of consent from the subject. * Lack of consent from legal representatives. * Failure to understand the instructions for performing the tests. In addition, for the control group: \- Suffering from scoliosis

Frequently Asked Questions

Who can join the NCT07356999 clinical trial?

This trial is open to participants of all sexes, aged 11 Years or older, up to 18 Years, studying Idiopathic Scoliosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07356999 currently recruiting?

Yes, NCT07356999 is actively recruiting participants. Visit ClinicalTrials.gov or contact Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française to inquire about joining.

Where is the NCT07356999 trial being conducted?

This trial is being conducted at Lyon, France.

Who is sponsoring the NCT07356999 clinical trial?

NCT07356999 is sponsored by Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology